Staging

The following is based on the original Ann Arbor staging system modified at a meeting in the Cotswolds, UK. The accuracy of staging will depend on the methods used. At the present time, CT scanning with contrast of abdomen, pelvis, chest, and neck is a key part of the staging process.

The Ann Arbor Staging System

The suffix “B” is added in presence of fever, night sweats, or significant weight loss (i.e., >10% over 6 months).


About this Canterbury DHB document (5946):
Document Owner:	Peter Ganly (see Who's Who)
Last Reviewed:	December 2021
Next Review:	December 2024
Keywords:
Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer The Haematology Department Protocols and Guidelines (the Red Book) are intended as a guide for registered health professionals to communicate guidelines and share best practices with supporting health professionals within New Zealand district health boards. They are not intended to be provided to or used as a reference for patients or non-registered health professionals. All health professionals must exercise their own clinical judgement and use pertinent clinical data when treating patients. The authors and editors of this publication have checked with sources believed to be reliable in their effort to provide information that is complete and in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical science, neither the authors, editors, publisher, nor any other party who has been involved in preparing or publishing this work warrants that the information contained in it is accurate or complete in every respect. They therefore have no liability (whether in tort (including negligence) or otherwise) for any loss or damage arising out of any reliance on this information. This publication has been compiled by the staff and contractors of Canterbury District Health Board (CDHB) and as such CDHB has copyright for this book. Amendments must be authorised in accordance with the documented process. No release of part of, or all of, this publication to any other party or organisation is permissible without the prior approval of the designated document owner.
Send Feedback Send Feedback	Expand All Drop-downs

Stage I	Involvement of a single lymph node region (I) or a single extra lymphatic organ or site (I_E).
Stage II	Involvement of 2 or more lymph node regions on the same side of the diaphragm (II) or localised involvement of an extra-lymphatic organ or site and if 1 or more lymph node regions on the same side of the diaphragm (II_E).
Stage III	Involvement of lymph node regions on both sides of the diaphragm (III), if spleen or extra-lymphatic organ/site involved (III_S / III_E) or, if both involved (III_SE). (III includes involvement of upper or lower abdominal lymphatic structure of their own).
Stage IV	Diffuse or disseminated involvement of 1 or more extra-lymphatic organs or tissues including marrow, with or without associated lymph node involvement.